Share on LinkedInShare on LinkedIn

ARTICLE · 09 MARCH 2015

Pomegranate Health Benefit Claims Were False, Misleading

The company appealed the Commission’s order on several grounds.

United StatesIntellectual Property

POM Wonderful, LLC, et al. v. Federal Trade Commission

In an opinion addressing the amount and type of scientific evidence required to substantiate disease treatment and prevention claims, the U.S. Court of Appeals for the District of Columbia upheld the Federal Trade Commission's finding that claims regarding the benefits of pomegranate juice with respect to various medical conditions were false or misleading but reduced (from two to one) the number of randomized, controlled trials demonstrating statistically significant results required to support future disease-related claims. POM Wonderful, LLC, et al. v. Federal Trade Commission, Case No. 13-1060 (D.C. Cir., Jan. 30, 2014) (Srinivasan, J.).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from